# Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure

Study · id `cardio:ct-nct07018297` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07018297](<https://clinicaltrials.gov/study/NCT07018297>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07018297

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.

## Technical summary

Registry record NCT07018297. Randomized; no masking; primary purpose treatment. Start 2028-08 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT07018297, source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)
- Planned start: 2028-08 (anticipated) (ClinicalTrials.gov record NCT07018297, source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2028-09-01 (anticipated) (ClinicalTrials.gov record NCT07018297, source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)
- Completion: 2028-09-01 (anticipated) (ClinicalTrials.gov record NCT07018297, source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07018297, source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07018297-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
- Condition: Heart Failure
- Condition: Acute Decompensated Heart Failure
- Intervention (Combination product): Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-Infusor
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)

## Provenance

Content hash: 4f7404a6b6896bbbca69f5a5cc97363f015ef32293c8d6987dbdd1c69814f43a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
